ADIL
ADIAL PHARMACEUTICALS, INC.
ADIAL PHARMACEUTICALS, INC. (ADIL) has 4 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 16, 2026.
The most active filer is 10% Owner Coastlands Capital LP with 5 filings. Insiders have net bought $106K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Cary John Claiborne
- Employees:5
- HQ:Charlottesville, VA, US
- IPO:2018-07-27
Insider Buying
$106K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$5.7M
latest known value
Related companies
ADIAL PHARMACEUTICALS, INC. is in the Healthcare sector.